** Shares of Boston Scientific BSX.N rise 2.5% to $105.69 premarket

** Medical device maker raises its annual adj EPS forecast to a range of $2.95 to $2.99, from its previous projection of $2.87 to $2.94

** BSX reports Q2 adj EPS of 75 cents, above Wall Street estimates of 72 cents - LSEG data

** Co posts Q2 revenue of $5.06 billion, beating analysts' avg estimate of $4.9 billion

** As of last close, stock up 15.5% YTD

(Reporting by Padmanabhan Ananthan and Puyaan Singh)

((Padmanabhan.Ananthan@thomsonreuters.com))